PREVACID FASTAB
As listed in the register: PREVACID FASTAB
30 mg · tablet (delayed-release)
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Lansoprazole
- Made by
- Takeda Pharmaceuticals America Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Lansoprazole). It describes the substance, not this exact product.
Lansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the (H +, K + )-ATPase enzyme system at the secretory surface of the gastric parietal cell.
Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production.
Lansoprazole is extensively metabolized in the liver.
Following single-dose oral administration of lansoprazole, virtually no unchanged lansoprazole was excreted in the urine.
Both the C max and AUC are diminished by about 50 to 70% if lansoprazole is given 30 minutes after food, compared to the fasting condition.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-24
Safety of the active substance
From the US prescribing label for the same active substance (Lansoprazole). It describes the substance, not this exact product.
- Lansoprazole delayed-release orally disintegrating tablets are contraindicated in patients with known hypersensitivity to any component of the formulation.
- Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see Warnings and Precautions (5.2), Adverse Reactions (6) ]..
- Proton Pump Inhibitors (PPIs), including lansoprazole delayed-release orally disintegrating tablets, are contraindicated with rilpivirine-containing products [see Drug Interactions (7) ]..
- For information about contraindications of antibacterial agents (clarithromycin and amoxicillin) indicated in combination with lansoprazole delayed-release orally disintegrating tablets, refer to the Contraindications section of their prescribing information..
Most commonly reported adverse reactions (≥1%): diarrhea, abdominal pain, nausea and constipation.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States9 matching products
Spain19 matching products
- OPIREN FLAS 30 mg lansoprazol · comprimido bucodispersable6 makers
- DOSTAB FLAS 30 mg · comprimido bucodispersable
- DUOMATE FLAS 30 mg · comprimido bucodispersable
- ESTOMIL FLAS 30 mg · comprimido bucodispersable
- LANSOPRAZOL FLAS ARISTO 30 mg · comprimido bucodispersable
- LANSOPRAZOL FLAS COMBIX 30 mg · comprimido bucodispersable
- LANSOPRAZOL FLAS QUALIGEN 30 mg · comprimido bucodispersable
- LANSOPRAZOL FLAS SALVAT 30 mg · comprimido bucodispersable
France7 matching products
- LANSOPRAZOLE ARROW 30 mg · comprimé orodispersible
- LANSOPRAZOLE BIOGARAN 30 mg · comprimé orodispersible
- LANSOPRAZOLE EG 30 mg · comprimé orodispersible
- LANSOPRAZOLE VIATRIS 30 mg · comprimé orodispersible
- LANSOPRAZOLE ZENTIVA 30 mg · comprimé orodispersible
- LANSOPRAZOLE ZYDUS 30 mg · comprimé orodispersible
- OGASTORO 30 mg · comprimé orodispersible
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Takeda Pharmaceuticals America Inc |
|---|---|
| Active substance | Lansoprazole |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 30 mg |
| Form | tablet (delayed-release) |
| Classification | A02BC03 · Digestion, stomach, diabetes and nutrition |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02249472 |
| DPD drug code | 73430 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet (delayed-release)2 products
- 15 mg
- 30 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.